Crosslinked Protein Delivery Strategy with Precise Activity Regulation Property for Cancer Therapy and Gene Editing

2022 ◽  
pp. 2102329
Author(s):  
Ning Liu ◽  
Lianghan Zhu ◽  
Honghao Sun ◽  
Zhanwei Zhou ◽  
Jingwen Dong ◽  
...  
2021 ◽  
pp. 1-13
Author(s):  
Shuang Luo ◽  
Yujiao Wang ◽  
Yongyu Tao ◽  
Shuo Li ◽  
Zirui Wang ◽  
...  

2019 ◽  
Vol 5 (12) ◽  
pp. eaay3255 ◽  
Author(s):  
Yuan Rui ◽  
David R. Wilson ◽  
John Choi ◽  
Mahita Varanasi ◽  
Katie Sanders ◽  
...  

Efficient cytosolic protein delivery is necessary to fully realize the potential of protein therapeutics. Current methods of protein delivery often suffer from low serum tolerance and limited in vivo efficacy. Here, we report the synthesis and validation of a previously unreported class of carboxylated branched poly(β-amino ester)s that can self-assemble into nanoparticles for efficient intracellular delivery of a variety of different proteins. In vitro, nanoparticles enabled rapid cellular uptake, efficient endosomal escape, and functional cytosolic protein release into cells in media containing 10% serum. Moreover, nanoparticles encapsulating CRISPR-Cas9 ribonucleoproteins (RNPs) induced robust levels of gene knock-in (4%) and gene knockout (>75%) in several cell types. A single intracranial administration of nanoparticles delivering a low RNP dose (3.5 pmol) induced robust gene editing in mice bearing engineered orthotopic murine glioma tumors. This self-assembled polymeric nanocarrier system enables a versatile protein delivery and gene editing platform for biological research and therapeutic applications.


2020 ◽  
Vol 8 (3) ◽  
pp. 949-959 ◽  
Author(s):  
Yuchen Wu ◽  
Shixian Lv ◽  
Yongjuan Li ◽  
Hua He ◽  
Yong Ji ◽  
...  

The introduction of donor-receptor coordination between micelles and drug payloads provides a precise co-delivery strategy for two different chemo-drugs with high drug loading and ROS responsiveness.


2020 ◽  
Vol 22 (3) ◽  
pp. 259-261 ◽  
Author(s):  
Katie Troike ◽  
Justin D. Lathia
Keyword(s):  

2020 ◽  
Vol 12 (11) ◽  
pp. 12478-12488 ◽  
Author(s):  
Ukrit Angkawinitwong ◽  
Aaron J. Courtenay ◽  
Aoife M. Rodgers ◽  
Eneko Larrañeta ◽  
Helen O. McCarthy ◽  
...  

2020 ◽  
Author(s):  
Victoria Yan ◽  
Kristine Yang ◽  
Elliot Ballato ◽  
Kenisha Arthur ◽  
Dimitra Georgiou ◽  
...  

Glycolysis inhibition remains aspirational in cancer therapy. We recently described a promising phosphonate inhibitor of Enolase for cancers harboring deletions in ENO1. Here, we describe the application of nitroheterocycle pro-drugs capitalizing on tumor hypoxia. These bioreducible pro-drugs exhibit up to 14-fold greater potency under hypoxic conditions compared to normoxia and exhibit robust stability in biological fluids. Our work provides strong proof-of-concept for using bioreduction as a pro-drug delivery strategy in the context of Enolase inhibition.


2017 ◽  
Vol 5 (8) ◽  
pp. 1367-1381 ◽  
Author(s):  
Shiyang Shen ◽  
Meng Liu ◽  
Teng Li ◽  
Shiqi Lin ◽  
Ran Mo

This review article highlights the recent progresses in nanomedicine-based combination cancer therapy via site-specific co-delivery strategies.


Amino Acids ◽  
2015 ◽  
Vol 48 (1) ◽  
pp. 157-168 ◽  
Author(s):  
Daniele Rubert Nogueira ◽  
Laís E. Scheeren ◽  
Letícia B. Macedo ◽  
Ana Isa P. Marcolino ◽  
M. Pilar Vinardell ◽  
...  

ACS Nano ◽  
2019 ◽  
Vol 13 (11) ◽  
pp. 12577-12590 ◽  
Author(s):  
Fenfen Zheng ◽  
Chen Wang ◽  
Tiantian Meng ◽  
Yuqian Zhang ◽  
Penghui Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document